Genetic Testing for Familial Hypercholesterolemia in a Pediatric Group: A Romanian Showcase

Diagnostics (Basel). 2023 Jun 7;13(12):1988. doi: 10.3390/diagnostics13121988.

Abstract

Familial hypercholesterolemia (FH) is a genetic disease marked by high levels of LDL-cholesterol. This condition has long-term clinical implications, such as cardiovascular events, that are evident during adult life. Here, we report on a single-center cross-sectional showcase study of genetic testing for FH in a Romanian pediatric group. Genetic testing for FH was performed on 20 Romanian pediatric patients, 10 boys and 10 girls, admitted with LDL-cholesterol levels over 130 mg/mL to the National Institute for Mother and Child Health "Alesssandrescu-Rusescu" in 2020. Genetic testing was performed using the Illumina TruSight Cardio panel. We identified pathogenic/likely pathogenic variants that could explain the phenotype in 5/20 cases. The involved genes were LDLR and APOB. Clinical signs that suggest the diagnosis of FH are scarce for the pediatric patient, although it can be diagnosed early during childhood by lipid panel screening. Prevention could prove lifesaving for some of these patients.

Keywords: genetic; hypercholesterolemia; pediatrics.

Grants and funding

This work is supported by the National Health Program (XIII Programul național de sănătate a femeii și copilului 2.3. Prevenirea bolilor genetice prin diagostic pre- și postnatal), POCU ProGeneRare-SMIS code 108073 and POCU/993/6/13/13472.